More collaboration between chief information officers (CIO) and chief marketing officers (CMO) at pharmaceutical companies could lead to more optimized use of digital technology, according to a survey from Accenture.
Accenture interviewed 22 CIOs and 24 CMOs from pharmaceutical companies in eight countries that were bringing in at least $5 billion in annual revenues.
While 91 percent of CIOs at...
Paul Ivans
As payors and providers advance toward outcomes-based medicine, that shift is affecting pharmaceutical companies as well. As decisions about prescribing shift away from the doctor, who has been the primary recipient of pharma marketing for the past 20 years, to the C-level of integrated delivery networks (IDNs) and accountable care organizations (ACOs), pharma is going to have to...
Qualcomm is already one of the biggest investors in digital health, according to Rock Health.
Qualcomm and Novartis, which announced a partnership just last week for mobile-enabled clinical trials, will also be banding together to start an investment firm, the companies announced ahead of the JP Morgan Healthcare event this week. Qualcomm Ventures and Novartis will leverage up to $100 million...
Proteus Digital Health
Out of all the digital health stakeholders, pharmaceutical companies have both one of the biggest opportunities and some of the most significant challenges to make the most of mobile and digital technologies. As such, while providers and payors have dived into the digital health world with gusto, moves from pharma have often been tentative. They are just now starting to...
